Valo Health · 21 hours ago
Senior Machine Learning Engineer
Valo Health is a human-centric, AI-enabled biotechnology company working to make new drugs for patients faster. They are seeking an experienced Senior Machine Learning Engineer to design and implement novel AI solutions to advance computationally accelerated drug development programs.
BiotechnologyHealth CareInformation TechnologyMedical
Responsibilities
Design, develop, test, maintain, and improve an integrated codebase of AI and machine learning tools
Work with data scientists, researchers, product teams, and other domain experts to build solutions for complex data-oriented problems
Develop solutions for advancing real-world preclinical discovery programs, tackling problems such as ADME modeling, toxicity prediction, and generative chemistry
Qualification
Required
A PhD (or Master's with experience) in Computer Science, Data Science or related technical field
Two years of experience applying modern ML/AI techniques to real-world problems with demonstrated business impact
Strong proficiency in python and modern ML frameworks (PyTorch, Hugging Face)
An aptitude for learning about new domains and adapting machine learning techniques to impact drug discovery
Experience with software engineering best practices and an ability to write clean, re-usable code in a collaborative environment
Experience and interest contributing to all stages of ML development and deployment
Strong analytical, problem-solving, and communication skills, including the ability to also condense, summarize, and synthesize those results into informative and actionable presentations to less technical audiences
Strong personal project management skills with demonstrated ability to deliver iterative results and balance tradeoffs between exploratory research and delivering short-term value
Benefits
Healthcare coverage
Annual incentive program
Retirement benefits
Broad range of other benefits
Company
Valo Health
Valo Health is a technology company focused on utilizing large scale data and AI-driven computation to discover and develop therapeutics.
Funding
Current Stage
Growth StageTotal Funding
$460MKey Investors
Koch Disruptive TechnologiesPSP InvestmentsFlagship Pioneering
2022-10-28Series C
2021-03-09Series B· $110M
2021-01-11Series B· $190M
Recent News
International Business Times
2025-12-18
Labiotech UG
2025-12-09
2025-12-03
Company data provided by crunchbase